Effects of ornithine α-ketoglutarate on protein metabolism in Yoshida sarcoma-bearing rats

Clinical Nutrition

Volumn 26, Issue 5, 2007, Pages 624-630

  Segaud, Frédéric ^a   Combaret, Lydie ^b   Neveux, Nathalie ^a,c   Attaix, Didier ^b   Cynober, Luc ^a,c   Moinard, Christophe ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CEMAGREF   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Cancer; Ornithine ketoglutarate; Proteasome; Proteolysis; Ubiquitin

Indexed keywords

3 METHYLHISTIDINE; AMINO ACID; MESSENGER RNA; ORNITHINE OXOGLUTARATE; PROTEASOME; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CACHEXIA; CATABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DOSE REDUCTION; DRUG EFFECT; MALE; MUSCLE ATROPHY; MUSCLE MASS; NITROGEN BALANCE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; SKELETAL MUSCLE; UBIQUITINATION; YOSHIDA SARCOMA;

ANIMALS; MALE; METHYLHISTIDINES; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORNITHINE; PROTEIN BIOSYNTHESIS; PROTEINS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SARCOMA, EXPERIMENTAL;

EID: 35448964721     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.05.001     Document Type: Article

References (38)

1. Tisdale M.J. Cancer cachexia. Br J Cancer 63 (1991) 337-342
2. De Bandt J.P., and Cynober L. Amino acids with anabolic properties. Curr Opin Clin Nutr Metab Care 1 (1998) 263-272
3. Cynober L.A. The use of alpha-ketoglutarate salts in clinical nutrition and metabolic care. Curr Opin Clin Nutr Metab Care 2 (1999) 33-37
4. Cynober L. Ornithine α-ketoglutarate. In: Cynober L. (Ed). Metabolic and therapeutic aspects of amino acids in clinical nutrition (2004), CRC Press, Boca Raton 633-646
5. Le Bricon T., Cynober L., and Baracos V.E. Ornithine α-ketoglutarate limits muscle protein breakdown without stimulating tumour growth in rats bearing Yoshida ascites hepatoma. Metabolism 43 (1994) 899-905
6. Le Bricon T., Cynober L., Field C.J., and Baracos V.E. Supplemental nutrition with ornithine α-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support. J Nutr 125 (1995) 2999-3010
7. Mulligan H.D., and Tisdale M.J. Metabolic substrate utilization by tumour and host tissues in cancer cachexia. Biochem J 277 Pt 2 (1991) 321-326
8. Medina M.A., Marquez J., and Nunez de Castro I. Interchange of amino acids between tumor and host. Biochem Med Metabol Biol 48 (1992) 1-7
9. Attaix D., Combaret L., Kee A., and Taillandier D. Mechanims of ubiquitination and proteasome-dependent proteolysis in skeletal muscle. In: Zempleni J., and Daniel H. (Eds). Molecular nutrition (2003), CABI Publishing, Wallingford 219-235
10. Lecker S.H., Solomon V., Mitch W.E., and Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129 (1999) 227S-237S
11. Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem 70 (2001) 503-533
12. Vaubourdolle M., Coudray-Lucas C., Jardel A., Ziegler F., Ekindjian O.G., and Cynober L. Action of enterally administered ornithine alpha-ketoglutarate on protein breakdown in skeletal muscle and liver of the burned rat. J Parenter Enteral Nutr 15 (1991) 517-520
13. Coudray-Lucas C., Le Bever H., Cynober L., De Bandt J.P., and Carsin H. Ornithine alpha-ketoglutarate improves wound healing in severe burn patients: a prospective randomized double-blind trial versus isonitrogenous controls. Crit Care Med 28 (2000) 1772-1776
14. De Bandt J.P., Coudray-Lucas C., Lioret N., et al. A randomized controlled trial of the influence of the mode of enteral ornithine-α-ketoglutarate adminstration in burned patients. J Nutr 128 (1998) 563-569
15. Temparis S., Asensi M., Taillandier D., et al. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 54 (1994) 5568-5573
16. Combaret L., Ralliere C., Taillandier D., Tanaka K., and Attaix D. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats. Mol Biol Rep 26 (1999) 95-101
17. Combaret L., Tilignac T., Claustre A., et al. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats. Biochem J 361 (2002) 185-192
18. Le Boucher J., Obled C., Farges M.C., and Cynober L. Ornithine alpha-ketoglutarate modulates tissue protein metabolism in burn-injured rats. Am J Physiol 273 (1997) E557-E563
19. Pernet P., Coudray-Lucas C., Schneid C., Jardel A., and Cynober L. Dose dependency of the effect of ornithine alpha-ketoglutarate on tissue glutamine concentrations and hypercatabolic response in endotoxaemic rats. Br J Nutr 92 (2004) 627-634
20. Smith P.K., Krohn R.I., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
21. Le Boucher J., Charret C., Coudray-Lucas C., Giboudeau J., and Cynober L. Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem 43 (1997) 1421-1428
22. Blanc M.C., Neveux N., Laromiguière M., Bérard M.P., and Cynober L. Evaluation of a newly available biochemical analyzer: the Olympus AU 600. Clin Chem Lab Med 38 (2000) 465-475
23. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
24. Cynober L, Coudray-Lucas C. Ornithine alpha-ketoglutarate administration in surgical, trauma and cancer bearing patients. In: Latifi R, Merrell RC, editors. Nutrition support in cancer and transplant patients; 2001. p. 144-155.
25. Wernerman J., Hammarqvist F., von der D.A., and Vinnars E. Ornithine-alpha-ketoglutarate improves skeletal muscle protein synthesis as assessed by ribosome analysis and nitrogen use after surgery. Ann Surg 206 (1987) 674-678
26. Hammarqvist F., Wernerman J., Ali R., and Vinnars E. Effects of an amino acid solution enriched with either branched chain amino acids or ornithine-alpha-ketoglutarate on the postoperative intracellular amino acid concentration of skeletal muscle. Br J Surg 77 (1990) 214-218
27. Sjölin J., Stjernström H., Arturson G., Andersson E., Friman G., and Larsson J. Exchange of 3-methylhistidine in the splanchnic region in human infection. Am J Clin Nutr 50 (1989) 1407-1414
28. Sjölin J., Stjernström H., Henneberg S., et al. Splanchnic and peripheral release of 3-methylhistidine in relation to its urinary excretion in human infection. Metabolism 38 (1989) 23-29
29. Combaret L., Taillandier D., Dardevet D., et al. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Biochem J 378 (2004) 239-246
30. Glass D.J. Molecular mechanisms modulating muscle mass. Trends Mol Med 9 (2003) 344-350
31. Burt M.E., Lowry S.F., Gorschboth C., and Brennan M.F. Metabolic alterations in a noncachectic animal tumor system. Cancer 47 (1981) 2138-2146
32. Kawamura I., Moldawer L.L., Keenan R.A., et al. Altered amino acid kinetics in rats with progressive tumor growth. Cancer Res 42 (1982) 824-829
33. Stein T.P., Oram-Smith J.C., Leskiw M.J., Wallace H.W., and Miller E.E. Tumor-caused changes in host protein synthesis under different dietary situations. Cancer Res 36 (1976) 3936-3940
34. Paxton K., Ward L.C., and Wilce P.A. Protein synthesis in the tumour-bearing rat. Biochem Int 14 (1987) 1055-1063
35. Strelkov A.B., Fields A.L., and Baracos V.E. Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. Am J Physiol 257 (1989) C261-C269
36. Tessitore L., Bonelli G., and Baccino F.M. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J 241 (1987) 153-159
37. Heys S.D., Park K.G.M., McNurlan M.A., Eremin O., and Garlick P.J. Protein metabolism in malignancy and the modulation of tumour growth by exogenous protein and amino acids. J Clin Nutr Gastroenterol 6 (1991) 118-130
38. Cynober L. Ornithine alpha-ketoglutarate as a potent precursor of arginine and nitric oxide: a new job for an old friend. J Nutr 134 (2004) 2858S-2862S